Intuitive Surgical SVP equity vesting and tax withholding
Intuitive Surgical SVP and Chief Manufacturing and Supply Chain Officer Mark Brosius reported equity vesting and related tax withholdings.
Rhea-AI Filing Summary
Intuitive Surgical SVP and Chief Manufacturing and Supply Chain Officer Mark Brosius reported equity vesting and related tax withholdings. On February 28, 2026, 8,378 performance stock units granted on February 28, 2023 and 877 restricted stock units granted on February 28, 2022 converted into common stock.
In connection with these settlements, 435 and 4,155 shares of common stock were withheld at a price of $503.51 per share to cover tax liabilities and exercise costs. After these transactions, Brosius directly owned 6,564 shares of Intuitive Surgical common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Performance Stock Units - 2-28-2023 | 8,378 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units - 2-28-2022 | 877 | $0.00 | $0.00 |
| Exercise | Common Stock | 877 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 435 | $503.51 | $219K |
| Exercise | Common Stock | 8,378 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 4,155 | $503.51 | $2.09M |
Footnotes (4)
- F1. RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.
- F2. Represents performance stock units ("PSUs") initially granted to the Reporting Person on February 28, 2023 subject to achievement of certain performance metrics. The performance criteria for the PSUs reported herein have been achieved, as determined by the Compensation Committee of the Issuer. The PSUs reported herein vest on February 28, 2026, the third anniversary of the grant date, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
- F3. This transaction represents the withholding of shares to cover taxes applicable to a settlement of PSUs reported on this Form 4.
- F4. Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Intuitive Surgical (ISRG) report for Mark Brosius?
Did the Intuitive Surgical Form 4 involve open-market stock sales or purchases?
How do Intuitive Surgical performance stock units and RSUs described here vest?
AI-generated analysis. How Rhea-AI works. Not financial advice.